Local immune response in skin of generalized vitiligo patients: Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site

Laboratory Investigation

Volumn 80, Issue 8, 2000, Pages 1299-1309

  Van Den Wijngaard, René ^a   Wankowicz Kalinska, Anna ^a   Le Poole, Caroline ^b   Tigges, Bert ^a   Westerhof, Wiete ^a,c   Das, Pranab ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c Dutch Institute for Pigmentary Disorders (SNIP)   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GRANZYME B; INTERCELLULAR ADHESION MOLECULE 1; LEUKOCYTE ANTIGEN; PERFORIN;

ADULT; ARTICLE; CELL INTERACTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACROPHAGE; MALE; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN DEFECT; T LYMPHOCYTE; VITILIGO;

EID: 0033889236     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780138     Document Type: Article

References (40)

1. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo
2. Cellular environments and apoptosis: Tissue microenvironments control activated T-cell death
3. Melanoma cells and normal melanocytes share antigens recognized by HLA- A2-restricted cytotoxic T cell clones from melanoma patients
4. An immunohistological study of cutaneous lymphocytes in vitiligo
5. Melanoma and vitiligo: Immunology's Grecian urn
6. An electron microscope study of basal melanocytes and high-level clear cells (Langerhans cells) in vitiligo
7. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
8. Functional evidence that the HECA-452 antigen is involved in the adhesion of human neutrophils and lymphocytes to tumour necrosis factor-alpha-stimulated endothelial cells
9. Cellular interactions and adhesion molecules in psoriatic skin
10. Melanocytes freshly isolated from normal human skin express the cell membrane receptor for the adhesive glycoprotein thrombospondin
11. Nitric oxide and apoptosis: Another paradigm for the double-edged role of nitric oxide
12. Cutting edge: Rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma
13. T cells in regenerating feathers of Smyth line chickens with vitiligo
14. + cells in normal and diseased human skin
15. Lymphocyte granule-mediated apoptosis: Matters of viral mimicry and deadly proteases
16. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo
17. Relationship between levels of soluble interleukin-2 receptors and the types and activity of vitiligo
18. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
19. Depletion and repopulation of Langerhans cells in nonsegmental type vitiligo
20. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis
21. Vitiligo
22. A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders
23. Presence of T cells and macrophages n inflammatory vitiligo skin parallels melanocyte disappearance
24. Presence or absence of melanocytes in vitiligo lesions: An immunohistochemical investigation
25. Phagocytosis by normal human melanocytes in vitro
26. On the etiology of vitiligo and gray hair
27. Apoptosis by death factor
28. Melanocyte destruction and repopulation in vitiligo
29. High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo
30. CD68 positive epidermal dendritic cells
31. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites
32. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis
33. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing
34. Cancer vaccines based on the identification of genes encoding cancer regression antigens
35. Recognition and phagocytosis of cells undergoing apoptosis
36. Practical suggestions for successful immunoenzyme double-staining immunoenzyme
37. Langerhans' cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation
38. Immunocytochemical detection of granzymes A and B in peripheral blood lymphocytes from healthy individuals after non-enzymatic antigen retrieval
39. Soluble interleukin-2 receptors in systemic lupus erythematosus
40. The immune response in halo nevi